Pharming Group (NASDAQ:PHGUF) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Wednesday. The brokerage currently has a $0.25 price objective on the stock. Zacks Investment Research’s target price suggests a potential upside of 2.04% from the stock’s previous close. According to Zacks, […]
